S. Hageman

Most-cited papers

1. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

   S. Hageman, L. Pennells, F. Ojeda, S. Kaptoge +171 more

   2021European Heart Journal1,556 citations Open access

   Semantic Scholar

   Save

2. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.

   T. D. de Vries, M. Cooney, R. Selmer, S. Hageman +30 more

   2021European Heart Journal530 citations Open access

   Semantic Scholar

   Save

3. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

   Lisa Stephen Helena Bleken Stephanie H Fabrizio Josep C Pennells Kaptoge Østergaard Read Carinci Franch-Na, L. Pennells, S. Kaptoge, H. B. Østergaard +84 more

   2023European Heart Journal275 citations Open access

   Semantic Scholar

   Save

4. Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP

   K. Matsushita, S. Kaptoge, S. Hageman, Y. Sang +55 more

   2022European Journal of Preventive Cardiology81 citations Open access

   Semantic Scholar

   Save

5. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort

   T. V. van Trier, M. Snaterse, S. Boekholdt, W. S. O. Scholte Op Reimer +5 more

   2023European Journal of Preventive Cardiology56 citations Open access

   Semantic Scholar

   Save

6. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

   S. Hageman, Ailsa J. McKay, P. Ueda, L. Gunn +23 more

   2022European Heart Journal56 citations Open access

   Semantic Scholar

   Save

7. Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model

   S. Hageman, Zijuan Huang, Hok-You Lee, S. Kaptoge +6 more

   2024European Heart Journal45 citations Open access

   Semantic Scholar

   Save

8. The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice.

   S. Hageman, J. Dorresteijn, L. Pennells, M. van Smeden +3 more

   2023European Journal of Preventive Cardiology39 citations Open access

   Semantic Scholar

   Save

9. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2

   S. Hageman, C. Petitjean, L. Pennells, S. Kaptoge +16 more

   2023European Journal of Preventive Cardiology38 citations Open access

   Semantic Scholar

   Save

10. Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands

    Maria C. Castelijns, M. A. Helmink, S. Hageman, F. Asselbergs +22 more

    2023BMJ Open34 citations Open access

    Semantic Scholar

    Save

11. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

    S. Hageman, S. Kaptoge, T. D. de Vries, Wentian Lu +78 more

    2024European Journal of Preventive Cardiology22 citations Open access

    Semantic Scholar

    Save

12. Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease

    S. Hageman, G. D. De Borst, Johannes A. N. Dorresteijn, M. Bots +3 more

    2020Heart19 citations Open access

    Semantic Scholar

    Save

13. Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model

    M. A. Helmink, S. Hageman, Björn Eliasson, N. Sattar +13 more

    2024Diabetes, obesity and metabolism15 citations Open access

    Semantic Scholar

    Save

14. Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease.

    T. V. van Trier, M. Snaterse, S. Hageman, N. ter Hoeve +9 more

    2023European Journal of Preventive Cardiology15 citations Open access

    Semantic Scholar

    Save

15. Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2).

    Helena Bleken Østergaard, S. Hageman, S. Read, Owen A. Taylor +14 more

    2022European Journal of Preventive Cardiology14 citations Open access

    Semantic Scholar

    Save

16. Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort.

    J. V. van Apeldoorn, S. Hageman, R. Harskamp, C. Agyemang +9 more

    2024International Journal of Cardiology10 citations Open access

    Semantic Scholar

    Save

17. Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention

    M. Gynnild, S. Hageman, J. Dorresteijn, O. Spigset +5 more

    2021Clinical Epidemiology10 citations Open access

    Semantic Scholar

    Save

18. Primary Prevention of Cardiovascular Disease in Asia: Challenges

    M. Dalakoti, Norman H.Y. Lin, J. Yap, Aaysha Cader +31 more

    2025JACC: Advances9 citations Open access

    Semantic Scholar

    Save

19. Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model

    T. Reitsma, G. Savarese, Ł. Kuźma, Salil V. Deo +25 more

    2026European Heart Journal8 citations Open access

    Semantic Scholar

    Save

20. Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular disease.

    S. Bijkerk, F. Visseren, M. G. van der Meer, G. D. De Borst +7 more

    2025European Journal of Preventive Cardiology8 citations

    Semantic Scholar

    Save

21. Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular Disease

    M. Poorthuis, S. Hageman, A. Fiolet, L. Kappelle +5 more

    2024Stroke8 citations

    Semantic Scholar

    Save

22. Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment

    M. Gynnild, S. Hageman, O. Spigset, S. Lydersen +4 more

    2022Open Heart8 citations Open access

    Semantic Scholar

    Save

23. External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease.

    Maria C. Castelijns, S. Hageman, M. Teraa, M. G. van der Meer +4 more

    2023American Heart Journal7 citations Open access

    Semantic Scholar

    Save

24. Estimating uncertainty when providing individual cardiovascular risk predictions: A Bayesian survival analysis.

    S. Hageman, R. Post, F. Visseren, J. W. Mcevoy +4 more

    2024Journal of Clinical Epidemiology6 citations Open access

    Semantic Scholar

    Save

25. Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model

    T. Reitsma, Carl-Emil Lim, M. Gynnild, S. Kaptoge +30 more

    2026European Heart Journal5 citations Open access

    Semantic Scholar

    Save

26. Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model

    Stephen Spencer J Tessa Wen Jennifer S Laura Mari Nordbø C Kaptoge Keene Reitsma Shi Lees Lõo Gynnild Chilala, S. Kaptoge, S. Keene, T. Reitsma +69 more

    2026European Heart Journal5 citations Open access

    Semantic Scholar

    Save

27. Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease

    Maria C. Castelijns, S. Hageman, M. Teraa, M. G. van der Meer +3 more

    2024Heart5 citations

    Semantic Scholar

    Save

28. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis

    M. D. de Winter, K. Thavorn, S. Hageman, M. Nijkeuter +1 more

    2023Research and Practice in Thrombosis and Haemostasis5 citations Open access

    Semantic Scholar

    Save

29. Identifying clinical phenotype clusters in patients with coronary artery disease

    J. Holtrop, C. Lim, A. Uijl, P. Ueda +8 more

    2025Heart4 citations Open access

    Semantic Scholar

    Save

30. Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery

    S. Ponnana, G. Mahalwar, J. Holtrop, S. Hageman +10 more

    2025American Heart Journal Plus: Cardiology Research and Practice4 citations Open access

    Semantic Scholar

    Save

31. SCORE2 Asia-Pacific: a comprehensive approach to prevention of cardiovascular disease.

    S. Hageman, S. Johar, F. Visseren

    2025European Heart Journal4 citations Open access

    Semantic Scholar

    Save

32. Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention

    S. Hageman, S. Kaptoge, M. Gynnild, J. Holtrop +14 more

    2025European Heart Journal - Quality of Care and Clinical Outcomes4 citations Open access

    Semantic Scholar

    Save

33. Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.

    M. A. Helmink, Sanne A. E. Peters, J. Westerink, Katie Harris +9 more

    2024European Journal of Preventive Cardiology4 citations Open access

    Semantic Scholar

    Save

34. SCORE2-ASIA risk prediction algorithms: revised models to estimate 10-year risk of cardiovascular disease in the Asia Pacific Region

    S. Hageman, Z. Huang, S. Kaptoge, L. Pennells +4 more

    2024European Heart Journal4 citations

    Semantic Scholar

    Save

35. External validation of the Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in cancer patients.

    M. Gynnild, J. Holtrop, S. Hageman, V. Vinje +6 more

    2025European Journal of Preventive Cardiology3 citations Open access

    Semantic Scholar

    Save

36. Low Attainment of Treatment Targets for Cardiovascular Risk Factors in Indonesian Adults With Established Coronary Artery Disease

    D. S. Arsyad, N. Qalby, A. Qanitha, Idar Mappangara +7 more

    2025Journal of Evaluation In Clinical Practice3 citations Open access

    Semantic Scholar

    Save

37. External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment

    M. Gynnild, V. Vinje, J. Holtrop, S. Hageman +6 more

    2024European Heart Journal3 citations

    Semantic Scholar

    Save

38. Very High Risk of Recurrent Cardiovascular Events in Indonesian Patients with Established Coronary Heart Disease

    D. S. Arsyad, S. Hageman, N. Qalby, Ansariadi +6 more

    2023Journal of Asian Pacific Society of Cardiology3 citations Open access

    Semantic Scholar

    Save

39. SCORE2 models allow consideration of sex-specific cardiovascular disease risks by region.

    S. Hageman, L. Pennells, F. Ojeda, S. Kaptoge +2 more

    2022European Heart Journal3 citations Open access

    Semantic Scholar

    Save

40. Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients

    M. Gynnild, Victoria Vinje-Jakobsen, J. Holtrop, S. Hageman +10 more

    2025JACC: Advances2 citations Open access

    Semantic Scholar

    Save

41. From reactive to proactive preventive cardiovascular risk management in primary care: a feasibility study

    V. Bongaerts, H. V. van Os, S. Hageman, L. V. van Gestel +5 more

    2024European Journal of Preventive Cardiology2 citations Open access

    Semantic Scholar

    Save

42. Variability in benefit from intensive insulin therapy on cardiovascular events in individuals with type 1 diabetes: A post hoc analysis of the DCCT/EDIC study

    M. A. Helmink, S. Hageman, F. Visseren, Wendela L. Ranitz-Greven +3 more

    2023Diabetic Medicine2 citations Open access

    Semantic Scholar

    Save

43. The value of additional risk factors for improving 10-year cardiovascular risk prediction in apparently healthy people

    S. Hageman, L. Pennells, R. Pajouheshnia, T. Tillmann +11 more

    2022European Heart Journal2 citations Open access

    Semantic Scholar

    Save

44. Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score.

    J. Holtrop, M. Gynnild, M. Richards, C. Lim +22 more

    2026European Journal of Preventive Cardiology1 citations Open access

    Semantic Scholar

    Save

45. Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.

    J. Holtrop, M. Gynnild, Salil V. Deo, Carl-Emil Lim +33 more

    2026European Heart Journal1 citations Open access

    Semantic Scholar

    Save

46. Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score

    T. Reitsma, J. Holtrop, M. Gynnild, C. Lim +11 more

    2025European Heart Journal1 citations

    Semantic Scholar

    Save

47. Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients.

    J. Holtrop, M. Gynnild, T. Dammen, H. Dalen +7 more

    2025European Journal of Preventive Cardiology1 citations Open access

    Semantic Scholar

    Save

48. Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions

    M. Dalakoti, Norman H.Y. Lin, Jonathan Yap, Aaysha Cader +31 more

    2025JACC: Advances1 citations Open access

    Semantic Scholar

    Save

49. Visceral adipose tissue quantity and dysfunction and the occurrence of major bleeding in patients with established cardiovascular disease.

    Maria C. Castelijns, S. Hageman, Y. Ruigrok, M. G. van der Meer +3 more

    2022Obesity Research and Clinical Practice1 citations Open access

    Semantic Scholar

    Save

50. Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness.

    S. Hageman, J. Dorresteijn, M. Bots, F. Asselbergs +19 more

    2021European Journal of Preventive Cardiology1 citations

    Semantic Scholar

    Save